Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 17/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.54 |
| ▸ | AOC2 | O75106 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19714903 | 0.86 | AOC3 (0.55) | AOC3KCNH2AOC2 | |
| SCHEMBL17611153 | 0.84 | AOC3 (0.69) | AOC3KCNH2 | |
| SCHEMBL17611096 | 0.82 | AOC3 (0.83) | AOC3KCNH2 | |
| SCHEMBL25765254 | 0.82 | AOC3 (0.65) | AOC3KCNH2 | |
| SCHEMBL17611177 | 0.82 | AOC3 (0.68) | AOC3KCNH2 | |
| SCHEMBL19714930 | 0.82 | AOC3 (0.49) | AOC3KCNH2AOC2 | |
| SCHEMBL21253827 | 0.81 | AOC3 (0.54) | AOC3KCNH2AOC2 | |
| SCHEMBL18976981 | 0.80 | AOC3 (0.75) | AOC3KCNH2AOC2 | |
| SCHEMBL17611083 | 0.78 | AOC3 (0.83) | AOC3KCNH2 | |
| SCHEMBL2602381 | 0.78 | AOC3 (0.69) | AOC3KCNH2AOC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3194388-B1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | PROXIMAGEN LLC (US) | 2019-08-14 | — | — | EP | disclosed |
| EP-3194388-B1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | PROXIMAGEN LLC (US) | 2019-08-14 | — | — | EP | disclosed |
| US-10065954-B2 | Substituted imidazo[4,5-c]pyridines as SSAO inhibitors | PROXIMAGEN LIMITED (GB) | 2018-09-04 | — | — | US | disclosed |
| US-20170362218-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | PROXIMAGEN, LLC | 2017-12-21 | — | — | US | disclosed |
| EP-3194388-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | Proximagen Limited (GB) | 2017-07-26 | — | — | EP | disclosed |
| WO-2016042331-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | PROXIMAGEN LIMITED (GB) | 2016-03-24 | — | — | WO | disclosed |
| WO-2016042331-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | PROXIMAGEN LIMITED (GB) | 2016-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362218-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | SSB, PNPO, SSBP1 | AOC3 24/4885KCNH2 2665/4885AOC2 20/4885 |
| US-10065954-B2 | Substituted imidazo[4,5-c]pyridines as SSAO inhibitors | MAOA, AOC2, AOC3 | AOC3 3/4885KCNH2 1289/4885AOC2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.